APA (7th ed.) Citation

B, G., JA, L., S, G., T, F., G, I., Z, P., . . . YG, S. (2023). MIJ821 (onfasprodil) in healthy volunteers: First-in-human, randomized, placebo-controlled study (single ascending dose and repeated intravenous dose). Clinical and translational science, 16(11), 2236. https://doi.org/10.1111/cts.13623

Chicago Style (17th ed.) Citation

B, Gomez-Mancilla, et al. "MIJ821 (onfasprodil) in Healthy Volunteers: First-in-human, Randomized, Placebo-controlled Study (single Ascending Dose and Repeated Intravenous Dose)." Clinical and Translational Science 16, no. 11 (2023): 2236. https://doi.org/10.1111/cts.13623.

MLA (9th ed.) Citation

B, Gomez-Mancilla, et al. "MIJ821 (onfasprodil) in Healthy Volunteers: First-in-human, Randomized, Placebo-controlled Study (single Ascending Dose and Repeated Intravenous Dose)." Clinical and Translational Science, vol. 16, no. 11, 2023, p. 2236, https://doi.org/10.1111/cts.13623.